Firing up Cold Tumors—Targeting the Epigenetic Machinery to Enhance Cancer Immunotherapy
Author Contributions
Funding
Conflicts of Interest
References
- Powles, T.; Park, S.H.; Voog, E.; Caserta, C.; Valderrama, B.P.; Gurney, H.; Kalofonos, H.; Radulović, S.; Demey, W.; Ullén, A.; et al. Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma. N. Engl. J. Med. 2020, 383, 1218–1230. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Wang, W.; Zhang, Y.; Cieślik, M.; Guo, J.; Tan, M.; Green, M.D.; Wang, W.; Lin, H.; Li, W.; et al. Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy. J. Clin. Investig. 2020, 130, 2712–2726. [Google Scholar] [CrossRef] [PubMed]
- Nagarsheth, N.; Peng, D.; Kryczek, I.; Wu, K.; Li, W.; Zhao, E.; Zhao, L.; Wei, S.; Frankel, T.L.; Vatan, L.; et al. PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. Cancer Res. 2016, 76, 275–282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Peng, D.; Kryczek, I.; Nagarsheth, N.; Zhao, L.; Wei, S.; Wang, W.; Sun, Y.; Zhao, E.; Vatan, L.; Szeliga, W.; et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nat. Cell Biol. 2015, 527, 249–253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, Y.-T.; Chuang, Y.-M.; Chan, M.W.Y. Combinatorial Epigenetic and Immunotherapy in Breast Cancer Management: A Literature Review. Epigenomes 2020, 4, 27. [Google Scholar] [CrossRef]
- Chiappinelli, K.B.; Strissel, P.L.; Desrichard, A.; Li, H.; Henke, C.; Akman, B.; Hein, A.; Rote, N.S.; Cope, L.M.; Snyder, A.; et al. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell 2015, 162, 974–986. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tie, C.H.; Fernandes, L.; Conde, L.; Robbez-Masson, L.; Sumner, R.P.; Peacock, T.; Rodriguez-Plata, M.T.; Mickute, G.; Gifford, R.; Towers, G.J.; et al. KAP 1 regulates endogenous retroviruses in adult human cells and contributes to innate immune control. EMBO Rep. 2018, 19. [Google Scholar] [CrossRef] [PubMed]
- Woods, D.M.; Woan, K.V.; Cheng, F.; Sodré, A.L.; Wang, D.; Wu, Y.; Wang, Z.; Chen, J.; Powers, J.; Pinilla-Ibarz, J.; et al. T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model. Blood 2017, 130, 146–155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, L.; Liu, Y.; Han, R.; Beier, U.H.; Bhatti, T.R.; Akimova, T.; Greene, M.I.; Hiebert, S.W.; Hancock, W.W. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3. J. Clin. Investig. 2015, 125, 3304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tan, A.H.Y.; Tu, W.; McCuaig, R.; Hardy, K.; Donovan, T.; Tsimbalyuk, S.; Forwood, J.K.; Rao, S. Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer. Front. Immunol. 2019, 10, 1351. [Google Scholar] [CrossRef] [PubMed]
- Lander, E.S.; Linton, L.M.; Birren, B.; Nusbaum, C.; Zody, M.C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W.; et al. International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome. Nat. Cell Biol. 2001, 409, 860–921. [Google Scholar] [CrossRef] [Green Version]
- Barrero, M.J. Epigenetic Regulation of the Non-Coding Genome: Opportunities for Immuno-Oncology. Epigenomes 2020, 4, 22. [Google Scholar] [CrossRef]
- Terranova-Barberio, M.; Pawlowska, N.; Dhawan, M.; Moasser, M.; Chien, A.J.; Melisko, M.E.; Rugo, H.; Rahimi, R.; Deal, T.; Daud, A.; et al. Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer. Nat. Commun. 2020, 11, 1–10. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lin, G.-L.; Tsai, L.H.J.; Kuppen, P.J.K.; Chan, M.W.Y. Firing up Cold Tumors—Targeting the Epigenetic Machinery to Enhance Cancer Immunotherapy. Epigenomes 2021, 5, 11. https://doi.org/10.3390/epigenomes5020011
Lin G-L, Tsai LHJ, Kuppen PJK, Chan MWY. Firing up Cold Tumors—Targeting the Epigenetic Machinery to Enhance Cancer Immunotherapy. Epigenomes. 2021; 5(2):11. https://doi.org/10.3390/epigenomes5020011
Chicago/Turabian StyleLin, Guan-Ling, Leah H. J. Tsai, Peter J. K. Kuppen, and Michael W. Y. Chan. 2021. "Firing up Cold Tumors—Targeting the Epigenetic Machinery to Enhance Cancer Immunotherapy" Epigenomes 5, no. 2: 11. https://doi.org/10.3390/epigenomes5020011